GB9923436D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9923436D0
GB9923436D0 GBGB9923436.1A GB9923436A GB9923436D0 GB 9923436 D0 GB9923436 D0 GB 9923436D0 GB 9923436 A GB9923436 A GB 9923436A GB 9923436 D0 GB9923436 D0 GB 9923436D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9923436.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Priority to GBGB9923436.1A priority Critical patent/GB9923436D0/en
Publication of GB9923436D0 publication Critical patent/GB9923436D0/en
Priority to HU0203311A priority patent/HUP0203311A3/en
Priority to CA002383306A priority patent/CA2383306A1/en
Priority to JP2001527776A priority patent/JP2003510346A/en
Priority to AU10206/01A priority patent/AU783911B2/en
Priority to MXPA02003440A priority patent/MXPA02003440A/en
Priority to PCT/EP2000/009576 priority patent/WO2001024777A1/en
Priority to NZ518033A priority patent/NZ518033A/en
Priority to CN00816583.1A priority patent/CN1402630A/en
Priority to EP00971305A priority patent/EP1217992A1/en
Priority to ARP000105197A priority patent/AR025938A1/en
Priority to TW089120543A priority patent/TWI233363B/en
Priority to ZA200203486A priority patent/ZA200203486B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
GBGB9923436.1A 1999-10-04 1999-10-04 Pharmaceutical compositions Ceased GB9923436D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB9923436.1A GB9923436D0 (en) 1999-10-04 1999-10-04 Pharmaceutical compositions
EP00971305A EP1217992A1 (en) 1999-10-04 2000-09-29 Coated solid dosage forms
PCT/EP2000/009576 WO2001024777A1 (en) 1999-10-04 2000-09-29 Coated solid dosage forms
CA002383306A CA2383306A1 (en) 1999-10-04 2000-09-29 Novel pharmaceutical compositions
JP2001527776A JP2003510346A (en) 1999-10-04 2000-09-29 New pharmaceutical composition
AU10206/01A AU783911B2 (en) 1999-10-04 2000-09-29 Coated solid dosage forms
MXPA02003440A MXPA02003440A (en) 1999-10-04 2000-09-29 Coated solid dosage forms.
HU0203311A HUP0203311A3 (en) 1999-10-04 2000-09-29 New pharmaceutical compositions of prolonged effect
NZ518033A NZ518033A (en) 1999-10-04 2000-09-29 Delayed release/slow release drugs lacking enteric coat
CN00816583.1A CN1402630A (en) 1999-10-04 2000-09-29 Novel pharmaceutical compositions
ARP000105197A AR025938A1 (en) 1999-10-04 2000-10-02 NEW PHARMACEUTICAL COMPOSITIONS.
TW089120543A TWI233363B (en) 1999-10-04 2000-10-03 Novel pharmaceutical compositions
ZA200203486A ZA200203486B (en) 1999-10-04 2002-05-02 Novel pharmaceutical compositions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9923436.1A GB9923436D0 (en) 1999-10-04 1999-10-04 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB9923436D0 true GB9923436D0 (en) 1999-12-08

Family

ID=10862090

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9923436.1A Ceased GB9923436D0 (en) 1999-10-04 1999-10-04 Pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP1217992A1 (en)
JP (1) JP2003510346A (en)
CN (1) CN1402630A (en)
AR (1) AR025938A1 (en)
AU (1) AU783911B2 (en)
CA (1) CA2383306A1 (en)
GB (1) GB9923436D0 (en)
HU (1) HUP0203311A3 (en)
MX (1) MXPA02003440A (en)
NZ (1) NZ518033A (en)
TW (1) TWI233363B (en)
WO (1) WO2001024777A1 (en)
ZA (1) ZA200203486B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
KR100434904B1 (en) * 2002-05-30 2004-06-11 주식회사 대웅 Enteric formulations containing stabilized lansoprazole
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
ITMI20030616A1 (en) * 2003-03-28 2004-09-29 Acme Drugs S R L METHOD FOR THE PREPARATION OF DRUGS, FOODS, FOOD SUPPLEMENTS, GASTROPROTECTS AND / OR CONTROLLED RELEASE, DIET PRODUCTS, PREMIXES FOR MANGIM, ADDITIVES FOR ZOOTECHNICAL FEEDING CONTAINING SENSITIVE ACTIVE INGREDIENTS
WO2005020954A2 (en) * 2003-09-03 2005-03-10 Agi Therapeutics Limited Proton pump inhibitor formulations, and methods of preparing and using such formulations
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
AR052225A1 (en) * 2004-11-04 2007-03-07 Astrazeneca Ab FORMULATIONS OF MODIFIED RELEASE TABLETS FOR INHIBITORS OF THE PUMP OF PROTONS
AR051654A1 (en) * 2004-11-04 2007-01-31 Astrazeneca Ab NEW FORMULATIONS OF MODIFIED RELEASE PELLETS FOR PROTON PUMP INHIBITORS
EP1762231B1 (en) * 2005-08-19 2010-10-27 Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG Sustained release magnesium microtablets
US20070298105A1 (en) * 2006-06-27 2007-12-27 Hwang Stephen S Methods of treating conditions by sustained release administration of benzimidazole derivatives
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
EP2398470A4 (en) * 2009-02-23 2013-03-06 Aptalis Pharmatech Inc Controlled-release compositions comprising a proton pump inhibitor
EA201290026A1 (en) 2009-06-25 2012-07-30 Астразенека Аб A METHOD FOR TREATING A PATIENT THAT HAS A RISK OF DEVELOPMENT OF ANALISM ASSOCIATED WITH THE RECEPTION OF NONSTEROID ANTI-INFLAMMATORY MEDIA
DK3326620T3 (en) 2010-12-16 2020-05-25 Novo Nordisk As SOLID COMPOSITIONS CONTAINING A GLP-1 AGONIST AND SALT OF N- (8- (2- HYDROXYBENZOYL) AMINO) CAPRYLIC ACID
MX355361B (en) 2011-04-12 2018-04-17 Novo Nordisk As Double-acylated glp-1 derivatives.
CN104519888A (en) 2011-12-28 2015-04-15 波曾公司 Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
EP4331667A2 (en) 2012-03-22 2024-03-06 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
AU2013234496B2 (en) 2012-03-22 2017-07-27 Novo Nordisk A/S Compositions of GLP-1 peptides and preparation thereof
HUE042757T2 (en) 2012-03-22 2019-07-29 Novo Nordisk As Compositions comprising a delivery agent and preparation thereof
ES2871328T3 (en) 2012-06-20 2021-10-28 Novo Nordisk As Tablet formulation comprising a peptide and a delivery agent
CN102846571A (en) * 2012-09-29 2013-01-02 南京正科制药有限公司 Esomeprazole magnesium micro-tablet
IL275778B2 (en) 2018-02-02 2023-12-01 Novo Nordisk As Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005771A1 (en) * 1991-09-27 1993-04-01 Fujisawa Pharmaceutical Co., Ltd. Long-acting preparation
FR2692146B1 (en) * 1992-06-16 1995-06-02 Ethypharm Sa Stable compositions of gastro-protected omeprazole microgranules and process for obtaining them.
AU4513393A (en) * 1992-07-17 1994-02-14 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
SE9704870D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
JP2000128779A (en) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc Controlled release medicine type preparation

Also Published As

Publication number Publication date
AR025938A1 (en) 2002-12-18
TWI233363B (en) 2005-06-01
HUP0203311A3 (en) 2004-06-28
NZ518033A (en) 2003-11-28
MXPA02003440A (en) 2004-09-10
EP1217992A1 (en) 2002-07-03
WO2001024777A1 (en) 2001-04-12
CA2383306A1 (en) 2001-04-12
AU1020601A (en) 2001-05-10
AU783911B2 (en) 2005-12-22
HUP0203311A2 (en) 2004-05-28
CN1402630A (en) 2003-03-12
JP2003510346A (en) 2003-03-18
ZA200203486B (en) 2003-08-04

Similar Documents

Publication Publication Date Title
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
PL351387A1 (en) Pharmaceutical composition
HU9901606D0 (en) Pharmaceutical compositions
HK1044476A1 (en) Medicinal compositions
GB9827996D0 (en) Pharmaceutical Compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
GB9923436D0 (en) Pharmaceutical compositions
EP1166786A4 (en) Medicinal compositions
AU3556400A (en) Pharmaceutical compositions
GB9904163D0 (en) Pharmaceutical compositions
GB9809213D0 (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
AU6460200A (en) Pharmaceutical compositions
HK1030552A1 (en) Pharmaceutical compositions
GB9904911D0 (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions
GB9902651D0 (en) Pharmaceutical compositions
IL130325A0 (en) Pharmaceutical compositions comprising allicin
GB9806487D0 (en) Pharmaceutical compositions
GB9902594D0 (en) Pharmaceutical compositions
GB9920652D0 (en) Pharmaceutical compositions
GB9902591D0 (en) Pharmaceutical compositions
GB9916413D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)